Clinical Trial Highlights

• All-Cause Mortality and Major Stroke Significantly Reduced with Iliofemoral CoreValve Replacement
• SORT-OUT VI: Zotarolimus-Eluting Stent Noninferior to Biolimus-Eluting Stent
• Prehospital Bivalirudin Improved Outcomes versus Heparin in Patients with Myocardial Infarction
• Similar Outcomes with Two-Stent and Provisional Stenting Techniques in Large Side Branch Bifurcation Lesions
• Tryton Two-Stent Strategy Safe, but Did Not Meet Noninferiority Endpoint
• No Change in Thrombotic Risk with Short-Term DAPT after Stenting
• Third-Generation ZES Matches EES in Efficacy and Safety, without Evidence of Longitudinal Deformation in an All-Comer Population
• Prolonged DAPT is Unnecessary Post-Stenting in Patients Who are Event-Free at 1 Year
• Risk of Major Cardiovascular or Cerebrovascular Events after PCI or CABG Increased in Diabetes Mellitus Patients Receiving Insulin
• Thrombectomy Does Not Prevent Microvascular Obstruction in Patients Undergoing PCI for NSTEMI